Australian researchers have developed a new AI tool called PSICHIC, which can decode protein-molecule interactions without the need for costly 3D structures, reducing the cost of drug discovery. This tool can effectively screen new drug candidates and distinguish the functional effects of compounds. University of Canterbury researchers are using digital twin technology to optimize mechanical ventilation, predicting the optimal settings for patients and potentially saving millions of dollars in ICU costs. Novari Health has partnered with Personify Care to offer integrated patient engagement solutions in Canada, the UK, Australia, and New Zealand, enhancing patient care and flow management.
Source link
Leveraging AI to lower drug discovery cost and more briefs
